Euglena Co., Ltd. (FRA:8EG)

Germany flag Germany · Delayed Price · Currency is EUR
2.140
+0.020 (0.94%)
Last updated: Apr 24, 2026, 8:03 AM CET
Market Cap304.24M -29.8%
Revenue (ttm)273.62M +5.8%
Net Income-4.37M
EPS-0.03
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividend0.01 (0.51%)
Ex-Dividend DateDec 29, 2025
Volumen/a
Average Volume690
Open2.140
Previous Close2.120
Day's Range2.140 - 2.140
52-Week Range1.930 - 2.920
Betan/a
RSI48.94
Earnings DateMay 14, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and socia... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 793
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8EG

Financial Performance

In 2025, Euglena's revenue was 50.37 billion, an increase of 5.78% compared to the previous year's 47.62 billion. Losses were -805.00 million, 23.8% more than in 2024.

Financial numbers in JPY Financial Statements